STAAR Surgical to Present at BMO Capital Markets Focus on Heathcare Conference in New York

Friday, August 1, 2008 General News J E 4
MONROVIA, Calif., July 31 STAAR Surgical Company(Nasdaq: STAA), a leading developer, manufacturer and marketer of minimallyinvasive ophthalmic products, today announced today that Barry G. Caldwell,President and Chief Executive Officer will present at the 2008 BMO CapitalMarkets Focus on Healthcare Conference at the Millennium Broadway Hotel onTuesday, August 5th at 10:45am Eastern Time.

Interested parties can access a live audio web cast of the presentation at A replay of the presentation will be available at thesame location.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketingof minimally invasive ophthalmic products employing proprietary technologies.STAAR's products are used by ophthalmic surgeons and include the Visian ICL, atiny, flexible lens implanted to correct refractive errors, as well asinnovative products designed to improve patient outcomes for cataracts andglaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by theFDA for use in treating myopia, has received CE Marking and is sold in morethan 40 countries. Collamer(R) is the brand name for STAAR's proprietarycollagen copolymer lens material. More information is available at Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Steve DiMattia 646-201-5445 Dahlia Bailey, 415-896-5862

SOURCE STAAR Surgical Company


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Sierra Neuropharmaceuticals Completes $21.5-Millio...
BioMed Realty Trust Reports Second Quarter 2008 Fi...